$ Value
$96K
Shares
1,444
Price
$67
Filed
May 5
Insider
Name
Lyski James
Title
EVP, Chief Growth & Strat Off
CIK
0001376853
Roles
Transaction Details
Transaction Date
2025-05-02
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,164
Footnotes
The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. | The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029.
Filing Info
Other Insiders at KMX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McCreight David W. | — | — | 2026-03-16 |
|
Barr Keith
President and CEO
|
— | — | 2026-03-16 |
|
Tuite Tyler
SVP & Chief Product Officer
|
— | — | 2026-03-22 |